
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Honda’s Biggest Flex Isn’t Its Superbikes, It’s Selling 500K Bikes In One Month - 2
Palestinians tell BBC they were sexually abused in Israeli prisons - 3
Canada Awards C$1.5 Billion Defense Contracts to L3Harris, Airbus - 4
Physicists and philosophers have long struggled to understand the nature of time: Here's why - 5
Dave Coulier shares new cancer diagnosis 1 year after revealing previous diagnosis
From Exemplary to Current: Famous Rings Available
Building an Individual Brand: Illustrations from Forces to be reckoned with
How to watch the last supermoon of the year
Flu activity rises sharply across US with 7.5 million cases, CDC data shows
Etymological Experiences on the Wireless transmissions: A Survey of \Learning in a hurry\ Language Web recording
Israel says 40 Hezbollah members killed as forces advance in Lebanon
EU foreign ministers commemorate Russian massacre in Bucha
Watch China's Shenzhou 22 rescue ship arrive at Tiangong space station (video)
If evolution is real, then why isn’t it happening now? An anthropologist explains that humans actually are still evolving












